Compounds > etoposide
Page last updated: 2024-08-23

etoposide and Central Nervous System Neoplasm

etoposide has been researched along with Central Nervous System Neoplasm in 106 studies

Research

Studies (106)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's20 (18.87)18.2507
2000's41 (38.68)29.6817
2010's40 (37.74)24.3611
2020's5 (4.72)2.80

Authors

AuthorsStudies
Andricopulo, AD; Beraldo, H; Da Silva, JG; Daghestani, H; Day, BW; Dos Santos, RG; Lessa, JA; Mendes, IC; Pesquero, JL; Rocha, WR; Salum, LB; Soares, MA; Vogt, A1
Grommes, C; Modelevsky, L; Reiss, SN; Yerram, P1
Abraham, J; Agbetiafa, K; Ahle, G; Bonmati, C; Bouabdallah, K; Bouabdallah, R; Bourget, P; Casasnovas, O; Charron, C; Chauchet, A; Chinot, O; Choquet, S; Cornillon, J; Damaj, G; Delwail, V; Dorvaux, V; Fabbro, M; Fornecker, LM; Ghesquières, H; Giordan, Q; Gressin, R; Gyan, E; Hoang-Xuan, K; Houillier, C; Houot, R; Jabeur, W; Jardin, F; Le Garff-Tavernier, M; Malaise, D; Marolleau, JP; Moluçon-Chabrot, C; Morschhauser, F; Nichelli, L; Oberic, L; Peyrade, F; Plessier, A; Roland, V; Schenone, L; Schmitt, A; Soussain, C; Taillandier, L; Tanguy, ML; Tempescul, A; Thieblemont, C; Touitou, V; Ursu, R; Wantz-Mézières, S; Waultier-Rascalou, A; Willems, L1
Butler, A; Chohan, M; Dandapani, M; Grundy, R; Jalloh, I; Liu, JF; Macarthur, D; Meijer, L; Parr, M; Walker, D; Wilne, S; Wilson, S1
Buckner, J; Duma, N; Halfdanarson, T; Reed, CT1
Alva, E; Bernstock, JD; Blount, J; Chagoya, G; Cohen, JL; Dhall, G; Elsayed, GA; Fiveash, JB; Friedman, GK; Johnston, JM; Li, R; Lobbous, M; Orr, BA; Reddy, AT; Rocque, B; Rozzelle, C1
Chou, YC; Fan, KH; Hsieh, CE; Hung, SP; Jaing, TH; Kao, WH; Lin, CY; Pai, PC; Tsang, NM; Tseng, CK; Wu, YY1
Ayed, AO; Chu, B; Farooq, U; Galanina, N; Link, BK; Malecek, MK; Maurer, M; Nabhan, C; Nowakowski, GS; Petrich, AM; Rozell, S; Trifilio, S1
Cuglievan, B; Garces, S; Menegaz, BA; Rytting, ME1
Adachi, JI; Mishima, K; Miyake, Y; Nishikawa, R; Sasaki, A; Suzuki, T1
Choi, DK; DiPatri, AJ; Lulla, RR; Marzec, S; Pillay-Smiley, N; Tomita, T; Wadhwani, NR1
Birsen, R; Blanc, E; Bouscary, D; Burroni, B; Damotte, D; Deau, B; Dezamis, E; Edjlali, M; Franchi, P; Houillier, C; Kirova, Y; Le Ray, E; Legoff, M; Pallud, J; Pilorge, S; Soussain, C; Tamburini, J; Varlet, P; Vignon, M; Willems, L1
Cohen, JB; Flowers, CR; Hall, KH; Panjic, EH; Valla, K1
Hong, JY; Huh, J; Hyung, J; Kim, JH; Kim, S; Lee, SW; Park, CS; Park, JS; Ryu, JS; Suh, C; Yoon, DH1
Batchelor, TT1
Baek, HJ; Han, JW; Im, HJ; Kang, HJ; Koh, KN; Lee, SH; Park, HJ; Park, KD; Sung, KW1
Choi, MK; Hoon Lim, D; Kang, ES; Kim, DW; Kim, SJ; Kim, WS; Ko, YH; Park, JH; Pyo, DH; Seok, H1
Hensel, M; Hentrich, M; Hoffmann, C; Mosthaf, F; Müller, M; Siehl, J; Wyen, C1
Imai, K; Kato, T; Miyao, K; Niimi, K; Ono, Y; Sakai, T; Sakemura, R; Sawa, M; Tsushita, N1
Cai, RQ; Chen, Y; Li, PF; Lu, SY; Sun, FF; Sun, XF; Wang, J; Wu, SX; Xia, YF; Yang, QY; Zhang, F; Zhen, ZJ; Zhu, J1
Anderson, JR; Barth, M; Cairo, MS; Frazer, JK; Galardy, P; Goldman, S; Gross, TG; Harrison, L; Perkins, SL; Sanger, W; Shiramizu, B; Smith, L; Weinstein, H1
Burbury, K; Carney, DA; Cheah, CY; Dickinson, M; Fedele, PL; George, A; Gilbertson, M; Harrison, SJ; Herbert, KE; Januszewicz, EH; Kennedy, GA; O'Rourke, K; Opat, SS; Prince, HM; Ritchie, DS; Seymour, JF; Tam, CS; Tan, SY; Westerman, DA; Wolf, M1
Ellin, F; Jerkeman, M; Landström, J; Relander, T1
Fujimaki, M; Hattori, N; Ichikawa, K; Kawajiri, S; Koike, M; Nakazato, T; Noda, K; Okuma, Y; Tomizawa, Y1
Beshlawi, I; Bhuyan, D; El-Banna, N; Elmanzalawy, A; Rabah, F1
Abramson, JS; Cassaday, R; Chavez, JC; Fenske, TS; Gandhi, M; Jaso, J; Landsburg, DJ; Medeiros, LJ; Nabhan, C; Petrich, AM; Press, O; Shah, N; Sohani, AR; Song, K; Yang, DT; Zelenetz, AD1
Burger, E; Ferreri, AJ; Finke, J; Fricker, H; Fritsch, K; Grishina, O; Ihorst, G; Illerhaus, G; Kasenda, B; Mikesch, K; Schorb, E; Valk, E; Zucca, E1
Chihara, D; Fanale, MA; Fayad, LE; Fowler, NH; Hagemeister, FB; Oki, Y; Westin, JR1
Ceylan, S; Gokturk, D; Kelebek, H; Yilmaz, DM1
Azad, A; Chionh, F; Lee, C1
Bell, SD; Bourekas, EC; Macnealy, MW; McGregor, JM; Newton, HB; Ray Chaudhury, A; Slone, HW1
Grodman, H; Kretschmar, C; Wolfe, L1
Allen, J; Chan, KW; Donahue, B; Holmes, E; Jakacki, R; Mehta, M; Miller, DC; Muraszko, K; Prados, M; Puccetti, D; Robertson, P; Rorke, LB; Sposto, R; Vezina, G1
Chang, JH; Cheong, JW; Hong, SJ; Kim, JS; Kim, KM; Kim, SJ; Lee, HW; Lee, ST; Min, YH1
Fouladi, M; Gajjar, A; Gronewold, L; Gururangan, S; Heideman, R; Kun, LE; Moghrabi, A; Phillips, P; Sanford, RA; Wallace, D1
Conrad, AL; Go, RS1
Duerst, R; Evans, L; Fouts, M; Goldman, S; Haut, P; Jacobsohn, D; Kletzel, M; Rademaker, A; Rosenfeld, A; Schaefer, C; Weinstein, J1
Biron, P; Blay, JY; Bosly, A; Casasnovas, O; Coiffier, B; Colin, P; Ferlay, C; Ghesquières, H; Haioun, C; Morel, P; Perol, D; Reman, O; Sebban, C; Tilly, H; Van den Neste, E1
Budning, A; Chan, HS; Dimaras, H; Doyle, JJ; Gallie, BL; Halliday, W; Héon, E1
Dhall, G; Fan, J; Finlay, JL; Gilles, F; Gonzalez, I; Jubran, R; Khatua, S; Krieger, M; Lavey, R; Marachelian, A; McComb, G; Nastia, A; Nelson, M; O'Neil, S; Olch, AJ; Panigrahy, A; Sposto, R; Villablanca, JG1
Choi, DR; Huh, J; Kim, S; Kim, SW; Lee, DH; Lee, JS; Lee, SW; Sohn, BS; Suh, C; Yoon, DH1
Al-Futaisi, A; Al-Kharusi, N; Biswas, J; Ganesh, A; Khetan, V; Kumar, K; Raja, T1
Bangert, A; Cristofanon, S; Debatin, KM; Fulda, S; Häcker, S1
Homma, C; Miwa, A; Sekiguchi, N; Shikai, T; Takezako, N; Takezako, Y; Tanimura, A; Yamagata, N1
Choquet, S; del Rio, MS; Fourme, E; Glaisner, S; Hoang-Xuan, K; Janvier, M; Soussain, C1
Fujii, M; Ito, M; Momota, H; Motomura, K; Natsume, A; Wakabayashi, T1
Cavallin-Stahl, E; Glass, B; Haenel, M; Kaiser, U; Loeffler, M; Pfreundschuh, M; Schmitz, N; Truemper, L; Wolf, M; Zeynalova, S1
Behler, CM; Cha, S; Damon, LE; Hwang, J; Issa, S; McDermott, M; O'Brien, J; Rubenstein, JL; Shuman, MA; Treseler, P; Valles, F; Wieduwilt, MJ1
Baek, HJ; Kim, HS; Lim, DH; Park, ES; Park, HJ; Park, KD; Sung, KW; Won, SC1
Barbieri, NL; Cordero, EA; Filippi-Chiela, EC; Garcia-Santos, D; Lenz, G; Lopez, PL; Pelegrini, AL; Reder, GM; Silva, AO1
Assanelli, A; Baldini, L; Caligaris-Cappio, F; Ferrari, A; Ferreri, AJ; Foppoli, M; Frezzato, M; Frungillo, N; Ilariucci, F; Licata, G; Mappa, S; Marturano, E; Proserpio, I; Reni, M; Sorarù, M; Stelitano, C; Vianello, F1
Ahn, HS; Kang, HJ; Kim, H; Lee, JW; Park, JD; Park, KD; Shin, HY; Yoon, JH1
Anderson, H; Björkholm, M; Delabie, J; Eriksson, M; Erlanson, M; Fluge, O; Fosså, A; Holte, H; Janes, R; Jerkeman, M; Jyrkkiö, S; Karjalainen-Lindsberg, ML; Kolstad, A; Leppä, S; Löfvenberg, E; Nordström, M; Ostenstad, B; Pedersen, LM; Sundström, C1
Kellie, SJ; Lockwood, L; Mauger, DC; Pozza, LD; Waters, KD; White, L; Wong, CK1
Balestrini, MR; Casanova, M; Cefalo, G; Colosimo, C; Di Rocco, C; Ferrari, A; Fossati-Bellani, F; Gandola, L; Genitori, L; Luksch, R; Massimino, M; Mazza, E; Navarria, P; Riccardi, R; Riva, D; Ruggiero, A; Spreafico, F; Terenziani, M; Tesoro-Tess, JD; Valentini, L1
Doolittle, ND; Kraemer, DF; Lacy, C; Neutwelt, EA; Siegal, T; Tyson, RM1
Kaur, H; Peereboom, DM; Singh, D1
McLean, TW1
Cerecedo-Díaz, F; Delgado-Huerta, S; Hernández-Contreras, I; López-Aguilar, E; Ramón-García, G; Rivera-Márquez, H; Rodríguez-Jiménez, H; Romo-Rubio, HA; Santacruz-Castillo, E; Sepúlveda-Vildósola, AC; Valdés-Sánchez, M; Wanzke-del Angel, V1
Abrey, LE; Anderson, ND; Caron, D; Correa, DD; Crump, M; DeAngelis, LM; Forsyth, P; Mason, WP; Moskowitz, CH; Nimer, SD; Paleologos, N; Stewart, D; Zelenetz, A1
Boyce, H; Brualdi, L; Diez, B; Dunkel, IJ; Finlay, JL; Kellie, SJ; Rosenblum, M1
Burholt, DR; Donovan, M; George, LD; Kornblith, PL; Marsh, JW1
Hoang-Xuan, K; Levy, V; Soussain, C1
Hondoh, H; Morii, K; Onda, K; Shinbo, Y; Takahashi, H; Takeuchi, S; Tamura, T; Tanaka, R; Yamanaka, R1
Mori, H; Nishiyama, K; Takahashi, H; Tanaka, R; Umezu, H; Yoshimura, J1
Benesch, M; Berthold, F; Wagner, S; Wolff, JE1
Brevet, M; Damaj, G; Garidi, R; Gruson, B; Royer, B; Vaida, I1
Dejligbjerg, M; Hofland, KF; Jensen, LH; Jensen, PB; Kristjansen, PE; Rengtved, P; Sehested, M; Thougaard, AV1
Adde, M; Enblad, G; Hagberg, H; Laurell, A; Sundström, C1
Bay, JO; Berthou, C; Bertrand, P; Brion, A; Camilleri-Broët, S; Colombat, P; Delepine, R; Delwail, V; Desablens, B; Lamy, T; Lemevel, A; Linassier, C; Rachieru, P1
Cagayan, MS; Lu-Lasala, LR1
Chang, CC; Gondo, G; Hayashi, A; Ito, S; Kanno, H; Kyuma, Y; Nishimura, S; Ono, A; Sasaki, T; Sato, H; Shimizu, N; Tanaka, M; Yamamoto, I1
Buyyounouski, MK; Cohen, RB; D'Ambrosio, DJ; Feigenberg, SJ; Glass, J; Konski, A1
Calugaru, V; Delattre, JY; Lang, P; Mazeron, JJ; Simon, JM; Taillibert, S1
Homma, J; Hondoh, H; Morii, K; Onda, K; Sano, M; Shinbo, Y; Takahashi, H; Tamura, T; Tanaka, R; Tsuchiya, N; Yajima, N; Yamanaka, R1
Bell, S; Doolittle, ND; Fortin, D; Jahnke, K; Knight, KR; Kraemer, DF; Muldoon, LL; Neuwelt, EA1
Ansell, S; Arndt, C; Buckner, J; Christianson, T; Galanis, E; Gill, P; Litzow, M; Moynihan, T1
Cheerva, AC; Gross, TG; Kadota, RP; Levine, JE; Ozkaynak, MF; Richards, MK; Rozans, MK; Sahdev, I; Shaw, PJ1
Homma, J; Hondoh, H; Kakuma, T; Morii, K; Sano, M; Shinbo, Y; Takahashi, H; Tamura, T; Tanaka, R; Tsuchiya, N; Yajima, N; Yamanaka, R1
Cai, QQ; Huang, HQ; Ling, JY; Sun, XF; Xia, Y; Yang, QY; Zhen, ZJ1
Douglass, EC; Gajjar, AJ; Greenwald, C; Heideman, RL; Jenkins, JJ; Kellie, SJ; Kovnar, EH; Langston, JA; Li, Y; Walter, AW1
Ezoe, A; Hirayama, Y; Kohda, K; Matsumoto, S; Matsunaga, T; Muramatsu, H; Nakazawa, O; Nobuoka, A; Takahashi, H; Watanabe, N1
Becker, NH; Carney, D; Elkind, R; Leaf, A; Sarta, C; Shah, M; Sparano, JA; Strack, M; Valentine, ES; Wiernik, PH1
Holm, B; Jensen, PB; Sehested, M1
Beretta, F; Cavalli, F; Ghielmini, M; Marini, G; Sanna, P1
DaSilva, V; Dent, S; Eapen, L; Girard, A; Hugenholtz, H; Stewart, DJ1
Balmaceda, C; Diez, B; Finlay, JL; Heller, G; Kellie, S; Leibel, S; Maher, P; Rosenblum, M; Villablanca, JG; Vlamis, V; Walker, RW1
Armata, J; Grześkowiak-Melanowska, J; Skoczeń, S1
Anderson, E; Anderson, T; Cameron, DA; Chetty, U; Craig, J; Dixon, M; Gabra, H; Hawkins, A; Jack, W; Kunkler, I; Lee, L; Leonard, R; Leonard, RC; MacKay, J; Matheson, L; Miller, W; Parker, AC1
Doughty, D; Kingston, JE; Plowman, PN; Sebag-Montefiore, D1
Cheng, AL; Hung, RL; Liu, MY; Uen, WC; Wang, CH; Yeh, KH1
Bouffet, E; Desjardins, L; Doz, F; Gentet, JC; Lutz, P; Michon, J; Namouni, F; Neuenschwander, S; Pacquement, H; Plantaz, D; Quintana, E; Tanguy, ML; Validire, P; Vannier, JP; Zucker, JM1
Kondo, E; Miura, A; Mizuno, H; Yamao, H; Yuge, M1
Buckner, JC; Groover, RV; Kimmel, DW; Neglia, J; O'Fallon, JR; Peethambaram, PP; Raffel, C; Schomberg, PJ; Shaw, EG; Smithson, WA1
Desai, J; Henry, DH; Llena, J; Mitnick, RJ; Sparano, JA1
Keyaki, A; Nabeshima, S; Waga, S1
Belasco, JB; Bunin, NJ; Lange, BJ; Leahey, AM; Meek, R; Scher, C1
Alvarnas, JC; Blume, KG; Chao, NJ; Horning, SJ; Hu, WW; Long, GD; Negrin, RS; Schriber, JR; Stockerl-Goldstein, K; Tierney, K; Wong, R1
Baker, D; Coccia, P; Cramer, LD; Dunkel, IJ; Finlay, JL; Garvin, J; Goldman, S; Kaplan, AM; Klemperer, M; Kramer, E; Packer, RJ; Papadakis, V; Papadopoulos, E; Strandjord, S; Willoughby, M1
Achour, E; Azar, N; Belanger, C; Cassoux, N; Delattre, JY; Gerber, S; Hoang-Xuan, K; Leblond, V; Levy, V; Ribrag, V; Soussain, C; Suzan, F1
Broxson, EH; Dole, MG; Dunkel, IJ; Filippa, DA; George, D; Heath, JA; Lyden, D1
Casanova, M; Cefalo, GS; Collini, P; Ferrari, A; Fossati-Bellani, F; Gasparini, M; Luksch, R; Massimino, M; Polastri, D; Spreafico, F; Terenziani, M1
Bowman, LC; Brenner, MK; Mirro, J; Santana, VM; Schell, MJ; Thompson, EI; Williams, R1
Watts, RG1
Mead, GM; Sweetenham, JW; Whitehouse, JM1
Douglass, EC; Fairclough, DL; Heideman, RL; Horowitz, ME; Jenkins, JJ; Kellie, SJ; Kovnar, EH; Kun, LE; Langston, JW; Sanford, RA1

Reviews

7 review(s) available for etoposide and Central Nervous System Neoplasm

ArticleYear
Craniospinal Germinomas in Patient with Down Syndrome Successfully Treated with Standard-Dose Chemotherapy and Craniospinal Irradiation: Case Report and Literature Review.
    World neurosurgery, 2017, Volume: 108

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Central Nervous System Neoplasms; Craniospinal Irradiation; Down Syndrome; Etoposide; Germinoma; Humans; Magnetic Resonance Imaging; Male; Neoplasms, Multiple Primary; Positron-Emission Tomography; Treatment Outcome

2017
Primary Central Nervous System Malignant Melanoma in Children: A Case Series and Review of the Literature.
    Journal of pediatric hematology/oncology, 2018, Volume: 40, Issue:8

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Chemoradiotherapy; Child, Preschool; Etoposide; Humans; Ipilimumab; Male; Melanoma; Temozolomide

2018
How to Decide Which DLBCL Patients Should Receive CNS Prophylaxis.
    Oncology (Williston Park, N.Y.), 2018, Volume: 32, Issue:6

    Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Humans; Injections, Spinal; Lymphoma, Large B-Cell, Diffuse; Methotrexate; Patient Selection; Prednisone; Risk Factors; Rituximab; Vincristine

2018
Contralateral testicular relapse after prophylactic radiation in a patient with primary testicular diffuse large B-cell lymphoma.
    European journal of haematology, 2009, Dec-01, Volume: 83, Issue:6

    Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Blood-Testis Barrier; Bone Marrow; Carboplatin; Central Nervous System Neoplasms; Cyclophosphamide; Disease Progression; Doxorubicin; Etoposide; Fatal Outcome; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Injections, Spinal; Lymphatic Metastasis; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Orchiectomy; Prednisone; Radiotherapy, Adjuvant; Remission Induction; Rituximab; Salvage Therapy; Testicular Neoplasms; Transplantation Conditioning; Treatment Failure; Vincristine

2009
Primary central nervous system germ cell tumors.
    Current treatment options in oncology, 2003, Volume: 4, Issue:6

    Topics: Antineoplastic Agents; Bleomycin; Carboplatin; Central Nervous System Neoplasms; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dose Fractionation, Radiation; Emergency Medical Services; Etoposide; Germinoma; Humans; Life Style; Mastectomy, Segmental; Salvage Therapy; Stereotaxic Techniques; Vinblastine; Vincristine

2003
Medulloblastomas and central nervous system primitive neuroectodermal tumors.
    Current treatment options in oncology, 2003, Volume: 4, Issue:6

    Topics: Antineoplastic Agents; Central Nervous System Neoplasms; Cerebellar Neoplasms; Cisplatin; Cyclophosphamide; Emergency Medical Services; Etoposide; Humans; Life Style; Lomustine; Medulloblastoma; Neuroectodermal Tumors, Primitive; Neurosurgical Procedures; Radiotherapy; Self-Help Groups; Social Support; Spinal Puncture; Vincristine

2003
[Neoadjuvant chemotherapy followed by radiotherapy adapted to the tumor response in the primary germinoma of the central nervous system: experience of the Pitié-Salpêtrière Hospital and review of literature].
    Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique, 2007, Volume: 11, Issue:3

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Cisplatin; Etoposide; Germinoma; Humans; Male; Neoadjuvant Therapy; Radiotherapy Dosage; Radiotherapy, Adjuvant; Remission Induction; Retrospective Studies

2007

Trials

33 trial(s) available for etoposide and Central Nervous System Neoplasm

ArticleYear
Treatment of pediatric high-grade central nervous system tumors with high-dose methotrexate in combination with multiagent chemotherapy: A single-institution experience.
    Pediatric blood & cancer, 2020, Volume: 67, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Child; Child, Preschool; Cisplatin; Cyclophosphamide; Dose-Response Relationship, Drug; Etoposide; Female; Follow-Up Studies; Humans; Infant; Male; Neoplasm Grading; Retrospective Studies; Survival Rate; Vincristine

2020
Rituximab with chemotherapy in children and adolescents with central nervous system and/or bone marrow-positive Burkitt lymphoma/leukaemia: a Children's Oncology Group Report.
    British journal of haematology, 2014, Volume: 167, Issue:3

    Topics: Adolescent; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Burkitt Lymphoma; Central Nervous System Neoplasms; Child; Consolidation Chemotherapy; Cyclophosphamide; Cytarabine; Disease-Free Survival; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Genes, myc; Humans; Immunotherapy; Infusions, Intravenous; Kaplan-Meier Estimate; Lymphoma, B-Cell; Maintenance Chemotherapy; Male; Methotrexate; Prednisone; Remission Induction; Rituximab; Typhlitis; Vincristine

2014
High-dose chemotherapy and autologous stem cell transplant compared with conventional chemotherapy for consolidation in newly diagnosed primary CNS lymphoma--a randomized phase III trial (MATRix).
    BMC cancer, 2016, Apr-21, Volume: 16

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Combined Modality Therapy; Cytarabine; Disease-Free Survival; Etoposide; Female; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Stem Cell Transplantation; Thiotepa; Transplantation, Autologous

2016
A phase II study of preradiotherapy chemotherapy followed by hyperfractionated radiotherapy for newly diagnosed high-risk medulloblastoma/primitive neuroectodermal tumor: a report from the Children's Oncology Group (CCG 9931).
    International journal of radiation oncology, biology, physics, 2009, Jul-15, Volume: 74, Issue:4

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Central Nervous System Neoplasms; Cerebellar Neoplasms; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Dose Fractionation, Radiation; Etoposide; Feasibility Studies; Female; Granulocyte Colony-Stimulating Factor; Humans; Male; Medulloblastoma; Neuroectodermal Tumors, Primitive; Vincristine; Young Adult

2009
Carboplatin-based primary chemotherapy for infants and young children with CNS tumors.
    Cancer, 2009, Jul-15, Volume: 115, Issue:14

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Central Nervous System Neoplasms; Chemotherapy, Adjuvant; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Etoposide; Humans; Infant; Survival Analysis; Time Factors; Treatment Outcome

2009
A phase II prospective study of sequential myeloablative chemotherapy with hematopoietic stem cell rescue for the treatment of selected high risk and recurrent central nervous system tumors.
    Journal of neuro-oncology, 2010, Volume: 97, Issue:2

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Central Nervous System Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Infant; Kaplan-Meier Estimate; Male; Melphalan; Thiotepa; Transplantation Conditioning

2010
Long-term follow-up of an age-adapted C5R protocol followed by radiotherapy in 99 newly diagnosed primary CNS lymphomas: a prospective multicentric phase II study of the Groupe d'Etude des Lymphomes de l'Adulte (GELA).
    Annals of oncology : official journal of the European Society for Medical Oncology, 2010, Volume: 21, Issue:4

    Topics: Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Lymphoma; Male; Methotrexate; Middle Aged; Societies, Medical; Time Factors; Vincristine; Young Adult

2010
Feasibility of BU, CY and etoposide (BUCYE), and auto-SCT in patients with newly diagnosed primary CNS lymphoma: a single-center experience.
    Bone marrow transplantation, 2011, Volume: 46, Issue:1

    Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Central Nervous System Neoplasms; Combined Modality Therapy; Cyclophosphamide; Etoposide; Feasibility Studies; Female; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma; Male; Middle Aged; Neoplasm Recurrence, Local; Recurrence; Remission Induction; Survival Analysis; Transplantation Conditioning; Transplantation, Autologous

2011
Ranimustine, ifosfamide, procarbazine, dexamethasone, and etoposide therapy for central nervous system recurrence of diffuse large B-cell lymphoma in patients with poor performance status: a pilot study.
    Leukemia & lymphoma, 2011, Volume: 52, Issue:10

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Dexamethasone; Etoposide; Female; Humans; Ifosfamide; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Nitrosourea Compounds; Pilot Projects; Procarbazine; Recurrence; Remission Induction; Survival Analysis; Treatment Outcome

2011
Immunochemotherapy with intensive consolidation for primary CNS lymphoma: a pilot study and prognostic assessment by diffusion-weighted MRI.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2012, Feb-15, Volume: 18, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Brain; Central Nervous System Neoplasms; Consolidation Chemotherapy; Cytarabine; Dacarbazine; Diffusion Magnetic Resonance Imaging; Etoposide; Female; Humans; Immunotherapy; Lymphoma; Male; Methotrexate; Middle Aged; Prognosis; Remission Induction; Rituximab; Survival Analysis; Temozolomide; Treatment Outcome

2012
Tandem high-dose chemotherapy and autologous stem cell transplantation in young children with atypical teratoid/rhabdoid tumor of the central nervous system.
    Journal of Korean medical science, 2012, Volume: 27, Issue:2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Central Nervous System Neoplasms; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Etoposide; Female; Follow-Up Studies; Humans; Induction Chemotherapy; Infant; Male; Prospective Studies; Recurrence; Rhabdoid Tumor; Salvage Therapy; Stem Cell Transplantation; Survival Rate; Thiotepa; Transplantation, Autologous

2012
Dose-densified chemoimmunotherapy followed by systemic central nervous system prophylaxis for younger high-risk diffuse large B-cell/follicular grade 3 lymphoma patients: results of a phase II Nordic Lymphoma Group study.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2013, Volume: 24, Issue:5

    Topics: Adult; Antibodies, Monoclonal, Murine-Derived; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System; Central Nervous System Neoplasms; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Humans; Immunotherapy; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neoplasm Recurrence, Local; Prednisone; Rituximab; Vincristine; Young Adult

2013
Activity of postoperative carboplatin, etoposide, and high-dose methotrexate in pediatric CNS embryonal tumors: results of a phase II study in newly diagnosed children.
    Medical and pediatric oncology, 2002, Volume: 39, Issue:3

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Central Nervous System Neoplasms; Chemotherapy, Adjuvant; Child; Child, Preschool; Disease-Free Survival; Etoposide; Female; Humans; Infant; Male; Medulloblastoma; Methotrexate; Neoplasms, Germ Cell and Embryonal; Prognosis; Treatment Outcome

2002
High response rate to cisplatin/etoposide regimen in childhood low-grade glioma.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2002, Oct-15, Volume: 20, Issue:20

    Topics: Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Child; Child, Preschool; Cisplatin; Etoposide; Female; Glioma; Hearing Disorders; Humans; Infant; Magnetic Resonance Imaging; Male; Survival Analysis

2002
Preirradiation ifosfamide, carboplatin and etoposide (ICE) for the treatment of high-grade astrocytomas in children.
    Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery, 2003, Volume: 19, Issue:12

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Carboplatin; Central Nervous System Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Male; Prospective Studies; Radiotherapy; Survival Rate

2003
Primary dissemination of high-grade gliomas in children: experiences from four studies of the Pediatric Oncology and Hematology Society of the German Language Group (GPOH).
    Journal of neuro-oncology, 2005, Volume: 72, Issue:2

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Etoposide; Female; Glioma; Humans; Male; Neoplasm Invasiveness; Radiotherapy; Retrospective Studies; Treatment Outcome; Vincristine

2005
First-line autologous stem cell transplantation in primary CNS lymphoma.
    European journal of haematology, 2005, Volume: 75, Issue:4

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Central Nervous System Neoplasms; Combined Modality Therapy; Cytarabine; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Immunocompetence; Lymphoma; Male; Melphalan; Middle Aged; Neurotoxicity Syndromes; Radiotherapy, Adjuvant; Recurrence; Remission Induction; Survival Rate; Transplantation, Autologous

2005
High-dose chemotherapy with autologous stem cell transplantation as first-line therapy for primary CNS lymphoma in patients younger than 60 years: a multicenter phase II study of the GOELAMS group.
    Bone marrow transplantation, 2006, Volume: 38, Issue:6

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Central Nervous System Neoplasms; Combined Modality Therapy; Cytarabine; Disease-Free Survival; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Lymphoma; Male; Methotrexate; Methylprednisolone; Middle Aged; Remission Induction; Stem Cell Transplantation; Transplantation, Autologous

2006
Salvage therapy and late neurotoxicity in patients with recurrent primary CNS lymphoma treated with a modified ProMACE-MOPP hybrid regimen.
    Leukemia & lymphoma, 2007, Volume: 48, Issue:6

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Lymphoma; Male; Mechlorethamine; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Neurotoxicity Syndromes; Prednisone; Procarbazine; Retrospective Studies; Salvage Therapy; Survival Analysis; Vincristine

2007
Intraarterial chemotherapy and osmotic blood-brain barrier disruption for patients with embryonal and germ cell tumors of the central nervous system.
    Cancer, 2008, Feb-01, Volume: 112, Issue:3

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Blood-Brain Barrier; Carboplatin; Central Nervous System Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Disease Progression; Etoposide; Female; Humans; Infant; Infusions, Intra-Arterial; Male; Methotrexate; Middle Aged; Neoplasms, Germ Cell and Embryonal; Prospective Studies; Survival Analysis; Treatment Outcome

2008
A pilot study of addition of amifostine to melphalan, carboplatin, etoposide, and cyclophosphamide with autologous hematopoietic stem cell transplantation in pediatric solid tumors-A pediatric blood and marrow transplant consortium study.
    Journal of pediatric hematology/oncology, 2008, Volume: 30, Issue:3

    Topics: Adolescent; Adult; Amifostine; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Bone Neoplasms; Carboplatin; Central Nervous System Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug-Related Side Effects and Adverse Reactions; Etoposide; Feasibility Studies; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Hypocalcemia; Kidney Neoplasms; Melphalan; Neoplasms; Neuroblastoma; Pilot Projects; Recurrence; Risk Factors; Sarcoma; Transplantation, Autologous; Transplantation, Homologous; Treatment Outcome; Wilms Tumor

2008
Preirradiation chemotherapy with carboplatin and etoposide in newly diagnosed embryonal pediatric CNS tumors.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1995, Volume: 13, Issue:9

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Central Nervous System Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Disease-Free Survival; Etoposide; Female; Humans; Male; Medulloblastoma; Neoplasms, Germ Cell and Embryonal; Neutropenia; Remission Induction; Survival Rate; Thrombocytopenia; Vincristine

1995
Infusional cyclophosphamide, doxorubicin and etoposide in HIV-related non-Hodgkin's lymphoma: a follow-up report of a highly active regimen.
    Leukemia & lymphoma, 1994, Volume: 14, Issue:3-4

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Follow-Up Studies; Humans; Infusions, Intravenous; Lymphocyte Subsets; Lymphoma, AIDS-Related; Lymphoma, Non-Hodgkin; Male; Middle Aged; Pilot Projects; Quality of Life

1994
PROMACE-MOPP and intrathecal chemotherapy for CNS lymphomas.
    Journal of neuro-oncology, 1996, Volume: 28, Issue:1

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Injections, Spinal; Lymphoma, Large B-Cell, Diffuse; Male; Mechlorethamine; Methotrexate; Middle Aged; Neurologic Examination; Prednisone; Procarbazine; Steroids; Survival Analysis; Vincristine

1996
Chemotherapy without irradiation--a novel approach for newly diagnosed CNS germ cell tumors: results of an international cooperative trial. The First International Central Nervous System Germ Cell Tumor Study.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1996, Volume: 14, Issue:11

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Central Nervous System Neoplasms; Child; Child, Preschool; Cyclophosphamide; Etoposide; Female; Germinoma; Humans; Infant; Male; Survival Rate

1996
High-dose chemotherapy supported by peripheral blood progenitor cells in poor prognosis metastatic breast cancer--phase I/II study. Edinburgh Breast Group.
    British journal of cancer, 1996, Volume: 74, Issue:12

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Central Nervous System Neoplasms; Chi-Square Distribution; Confidence Intervals; Diarrhea; Disease-Free Survival; Etoposide; Female; Hematologic Diseases; Hematopoietic Stem Cell Transplantation; Herpes Zoster; Humans; Liver Neoplasms; Lung Neoplasms; Melphalan; Middle Aged; Neoplasm Staging; Survival Rate; Thiotepa; Treatment Outcome

1996
Phase II trial of primary chemotherapy followed by reduced-dose radiation for CNS germ cell tumors.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1999, Volume: 17, Issue:3

    Topics: Adolescent; Adult; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Child; Chorionic Gonadotropin; Cisplatin; Combined Modality Therapy; Etoposide; Female; Germinoma; Hematologic Diseases; Humans; Male; Prospective Studies; Radiotherapy Dosage; Remission Induction; Vomiting

1999
[Combined modality therapy for malignant lymphoma of the primary central nervous system: a preliminary report of a new chemotherapeutic regimen with "PEACE"].
    No shinkei geka. Neurological surgery, 1999, Volume: 27, Issue:11

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Central Nervous System Neoplasms; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Procarbazine; Treatment Outcome

1999
Novel multiagent chemotherapy for bone marrow relapse of pediatric acute lymphoblastic leukemia.
    Medical and pediatric oncology, 2000, Volume: 34, Issue:5

    Topics: Adolescent; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow; Bone Marrow Transplantation; Central Nervous System Neoplasms; Child; Child, Preschool; Cytarabine; Dexamethasone; Disease-Free Survival; Etoposide; Female; Follow-Up Studies; Humans; Idarubicin; Infant; Injections, Spinal; Male; Neoplasm Recurrence, Local; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Remission Induction; Vincristine

2000
Results of intensive chemotherapy followed by hematopoietic stem-cell rescue in 22 patients with refractory or recurrent primary CNS lymphoma or intraocular lymphoma.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2001, Feb-01, Volume: 19, Issue:3

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Central Nervous System Neoplasms; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Disease-Free Survival; Dose-Response Relationship, Drug; Etoposide; Eye Neoplasms; Feasibility Studies; Female; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Large-Cell, Immunoblastic; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Nervous System Diseases; Salvage Therapy; Thiotepa

2001
Intensive, very short-term chemotherapy for advanced Burkitt's lymphoma in children.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2002, Jun-15, Volume: 20, Issue:12

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Central Nervous System Neoplasms; Child; Child, Preschool; Cisplatin; Cyclophosphamide; Cytarabine; Disease-Free Survival; Dose-Response Relationship, Drug; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Infusions, Intravenous; Injections, Spinal; Male; Methotrexate; Palliative Care; Prognosis; Risk Factors; Treatment Outcome; Vincristine

2002
Escalating sequential high-dose carboplatin and etoposide with autologous marrow support in children with relapsed solid tumors.
    Bone marrow transplantation, 1992, Volume: 10, Issue:5

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carboplatin; Central Nervous System Neoplasms; Chemical and Drug Induced Liver Injury; Child; Child, Preschool; Combined Modality Therapy; Dose-Response Relationship, Drug; Etoposide; Female; Gastrointestinal Diseases; Hodgkin Disease; Humans; Infusions, Intravenous; Male; Neoplasm Recurrence, Local; Neuroblastoma; Neutropenia; Thrombocytopenia

1992
Neuraxis dissemination in pediatric brain tumors. Response to preirradiation chemotherapy.
    Cancer, 1992, Feb-15, Volume: 69, Issue:4

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Drug Evaluation; Etoposide; Humans; Magnetic Resonance Imaging; Myelography; Neoplasm Staging

1992

Other Studies

66 other study(ies) available for etoposide and Central Nervous System Neoplasm

ArticleYear
N⁴-Phenyl-substituted 2-acetylpyridine thiosemicarbazones: cytotoxicity against human tumor cells, structure-activity relationship studies and investigation on the mechanism of action.
    Bioorganic & medicinal chemistry, 2012, Jun-01, Volume: 20, Issue:11

    Topics: Adenocarcinoma; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Death; Cell Line, Tumor; Central Nervous System Neoplasms; Crystallography, X-Ray; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Etoposide; Female; Glioblastoma; Glioma; Humans; Inhibitory Concentration 50; Microtubules; Molecular Structure; Structure-Activity Relationship; Thiosemicarbazones; Tubulin; Tumor Suppressor Protein p53

2012
Rituximab, Methotrexate, Carmustine, Etoposide, and Prednisone (RMBVP) for the treatment of relapsed/refractory primary central nervous system lymphoma: a retrospective single-center study.
    Leukemia & lymphoma, 2022, Volume: 63, Issue:3

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Central Nervous System; Central Nervous System Neoplasms; Etoposide; Female; Humans; Lymphoma, Non-Hodgkin; Methotrexate; Neoplasm Recurrence, Local; Prednisone; Retrospective Studies; Rituximab

2022
Intensive chemotherapy followed by autologous stem cell transplantation in primary central nervous system lymphomas (PCNSLs). Therapeutic outcomes in real life-experience of the French Network.
    Bone marrow transplantation, 2022, Volume: 57, Issue:6

    Topics: Antineoplastic Combined Chemotherapy Protocols; Busulfan; Carmustine; Central Nervous System; Central Nervous System Neoplasms; Cyclophosphamide; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma; Neoplasm Recurrence, Local; Prospective Studies; Thiotepa; Transplantation, Autologous; Treatment Outcome

2022
Evaluating the efficacy and safety of single-agent etoposide intra-CSF chemotherapy in children and young people with relapsed/refractory central nervous system tumours.
    Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery, 2023, Volume: 39, Issue:6

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Child; Child, Preschool; Etoposide; Humans; Progression-Free Survival; Quality of Life

2023
Primary neuroendocrine carcinoma of the brain.
    BMJ case reports, 2019, Sep-18, Volume: 12, Issue:9

    Topics: Adult; Antineoplastic Agents; Carcinoma, Neuroendocrine; Central Nervous System Neoplasms; Cisplatin; Combined Modality Therapy; Etoposide; Fatal Outcome; Female; Humans; Magnetic Resonance Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Ventriculoperitoneal Shunt

2019
Treatment of Primary Central Nervous System Germinomas With Short-course Induction Chemotherapy Followed by Low-dose Radiotherapy Without a Tumor Bed Boost: Prognostic Impact of Human Chorionic Gonadotropin.
    Journal of pediatric hematology/oncology, 2021, 10-01, Volume: 43, Issue:7

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Chemoradiotherapy; Child; Chorionic Gonadotropin; Cisplatin; Etoposide; Female; Follow-Up Studies; Germinoma; Humans; Induction Chemotherapy; Male; Prognosis; Radiotherapy Dosage; Retrospective Studies; Survival Rate; Young Adult

2021
Frequency, risk factors, and outcomes of central nervous system relapse in lymphoma patients treated with dose-adjusted EPOCH plus rituximab.
    American journal of hematology, 2017, Volume: 92, Issue:11

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Central Nervous System Neoplasms; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Prednisone; Premedication; Retreatment; Risk Factors; Rituximab; Survival Analysis; Treatment Outcome; Vincristine; Young Adult

2017
Acute myeloid leukaemia masquerading as a primary CNS tumour.
    BMJ case reports, 2017, Aug-11, Volume: 2017

    Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Central Nervous System Neoplasms; Child, Preschool; Cytarabine; Daunorubicin; Etoposide; fms-Like Tyrosine Kinase 3; Humans; In Situ Hybridization, Fluorescence; Leukemia, Myeloid, Acute; Magnetic Resonance Imaging; Male; Sarcoma, Myeloid; Treatment Outcome

2017
Efficacy and safety of high-dose etoposide cytarabine as consolidation following rituximab methotrexate temozolomide induction in newly diagnosed primary central nervous system lymphoma in immunocompetent patients.
    Haematologica, 2018, Volume: 103, Issue:7

    Topics: Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Consolidation Chemotherapy; Cytarabine; Etoposide; Humans; Lymphoma; Remission Induction; Survival Analysis; Treatment Outcome

2018
Thiotepa, busulfan, and cyclophosphamide or busulfan, cyclophosphamide, and etoposide high-dose chemotherapy followed by autologous stem cell transplantation for consolidation of primary central nervous system lymphoma.
    Annals of hematology, 2019, Volume: 98, Issue:7

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Autografts; Busulfan; Central Nervous System Neoplasms; Consolidation Chemotherapy; Cyclophosphamide; Disease-Free Survival; Etoposide; Female; Follow-Up Studies; Humans; Induction Chemotherapy; Lymphoma; Male; Middle Aged; Prospective Studies; Registries; Stem Cell Transplantation; Survival Rate; Thiotepa

2019
Flying solo: chemotherapy without radiation for primary CNS lymphoma.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2013, Sep-01, Volume: 31, Issue:25

    Topics: Central Nervous System Neoplasms; Cranial Irradiation; Cytarabine; Etoposide; Humans; Lymphoma, Non-Hodgkin

2013
Myeloablative chemotherapy and autologous stem cell transplantation in patients with relapsed or progressed central nervous system germ cell tumors: results of Korean Society of Pediatric Neuro-Oncology (KSPNO) S-053 study.
    Journal of neuro-oncology, 2013, Volume: 114, Issue:3

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Central Nervous System Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Etoposide; Feasibility Studies; Female; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Humans; Male; Melphalan; Myeloid Cells; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Prognosis; Prospective Studies; Salvage Therapy; Survival Rate; Thiotepa; Transplantation, Autologous; Young Adult

2013
Treatment outcome of relapsed/refractory primary central nervous system diffuse large B-cell lymphoma: a single-center experience of autologous stem cell transplantation.
    International journal of hematology, 2013, Volume: 98, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Central Nervous System Neoplasms; Combined Modality Therapy; Dexamethasone; Etoposide; Female; Humans; Ifosfamide; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Retrospective Studies; Salvage Therapy; Stem Cell Transplantation; Transplantation, Autologous; Treatment Outcome; Young Adult

2013
Therapy of HIV-associated lymphoma-recommendations of the oncology working group of the German Study Group of Physicians in Private Practice Treating HIV-Infected Patients (DAGNÄ), in cooperation with the German AIDS Society (DAIG).
    Annals of hematology, 2014, Volume: 93, Issue:6

    Topics: Anti-HIV Agents; Antibiotic Prophylaxis; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Antiretroviral Therapy, Highly Active; Castleman Disease; Central Nervous System Neoplasms; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Drug Interactions; Etoposide; Hematopoietic Stem Cell Transplantation; HIV Infections; Humans; Lymphoma, AIDS-Related; Methotrexate; Neoplasm Staging; Prednisolone; Prednisone; Radiotherapy, Adjuvant; Risk Assessment; Rituximab; Vincristine

2014
Upfront autologous stem-cell transplantation with melphalan, cyclophosphamide, etoposide, and dexamethasone (LEED) in patients with newly diagnosed primary central nervous system lymphoma.
    International journal of hematology, 2014, Volume: 100, Issue:2

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Cyclophosphamide; Cytarabine; Dexamethasone; Etoposide; Female; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Melphalan; Methotrexate; Middle Aged; Remission Induction; Retrospective Studies; Stem Cell Transplantation; Survival Analysis; Transplantation, Autologous; Treatment Outcome

2014
The clinical characteristics and treatment outcome of 57 children and adolescents with primary central nervous system germ cell tumors.
    Chinese journal of cancer, 2014, Volume: 33, Issue:8

    Topics: Adolescent; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Central Nervous System Neoplasms; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Etoposide; Female; Humans; Male; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Retrospective Studies; Survival Rate; Treatment Outcome

2014
A multicentre retrospective comparison of central nervous system prophylaxis strategies among patients with high-risk diffuse large B-cell lymphoma.
    British journal of cancer, 2014, Sep-09, Volume: 111, Issue:6

    Topics: Acute Kidney Injury; Administration, Intravenous; Adolescent; Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Cyclophosphamide; Cytarabine; Dexamethasone; Disease-Free Survival; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Injections, Spinal; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Middle Aged; Prednisone; Recurrence; Retrospective Studies; Risk Assessment; Rituximab; Survival Rate; Vincristine; Young Adult

2014
Central nervous system relapse in peripheral T-cell lymphomas: a Swedish Lymphoma Registry study.
    Blood, 2015, Jul-02, Volume: 126, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Alemtuzumab; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Autografts; Central Nervous System Neoplasms; Cyclophosphamide; Doxorubicin; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, T-Cell, Peripheral; Male; Middle Aged; Prednisolone; Prednisone; Recurrence; Registries; Sweden; Vincristine

2015
Lymphomatoid Granulomatosis with Central Nervous System Involvement Successfully Treated with Cyclophosphamide, High-dose Cytarabine, Dexamethasone, Etoposide, and Rituximab (CHASER therapy) Followed by Brain Irradiation: A Case Study.
    CNS neuroscience & therapeutics, 2015, Volume: 21, Issue:7

    Topics: Adult; Antineoplastic Agents; Central Nervous System Neoplasms; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dexamethasone; Etoposide; Female; Humans; Lymphomatoid Granulomatosis; Rituximab

2015
A Demyelinating Disease; What Lies Beneath?
    Indian journal of pediatrics, 2016, Volume: 83, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Brain; Central Nervous System Neoplasms; Child, Preschool; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Cytarabine; Demyelinating Diseases; Diagnosis, Differential; Doxorubicin; Encephalomyelitis, Acute Disseminated; Etoposide; Humans; Hydrocortisone; Leucovorin; Lymphoma, Large B-Cell, Diffuse; Magnetic Resonance Imaging; Male; Methotrexate; Prednisone; Vincristine

2016
Impact of oncogene rearrangement patterns on outcomes in patients with double-hit non-Hodgkin lymphoma.
    Cancer, 2016, Feb-15, Volume: 122, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Neoplasms; Burkitt Lymphoma; Central Nervous System Neoplasms; Cohort Studies; Cyclophosphamide; Cytarabine; Databases, Factual; Dexamethasone; DNA-Binding Proteins; Doxorubicin; Etoposide; Female; Gene Rearrangement; Genes, bcl-2; Genes, myc; Germinal Center; Humans; Ifosfamide; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisone; Prognosis; Proto-Oncogene Proteins c-bcl-6; Rituximab; Survival Rate; Vincristine

2016
Dose-Adjusted EPOCH-R and Mid-Cycle High Dose Methotrexate for Patients with Systemic Lymphoma and secondary CNS Involvement.
    British journal of haematology, 2017, Volume: 179, Issue:5

    Topics: Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Lymphoma; Methotrexate; Prednisone; Rituximab; Treatment Outcome; Vincristine

2017
The Effect of Ascorbic Acid over the Etoposide- and Temozolomide-Mediated Cytotoxicity in Glioblastoma Cell Culture: A Molecular Study.
    Turkish neurosurgery, 2018, Volume: 28, Issue:1

    Topics: Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Ascorbic Acid; Brain Neoplasms; Cell Line, Tumor; Cell Proliferation; Central Nervous System Neoplasms; Dacarbazine; DNA Damage; Drug Synergism; Etoposide; Glioblastoma; Humans; Temozolomide

2018
Small cell carcinoma of unknown primary presenting with disease confined to the central nervous system.
    Acta oncologica (Stockholm, Sweden), 2009, Volume: 48, Issue:2

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Central Nervous System Neoplasms; Combined Modality Therapy; Disease-Free Survival; Etoposide; Female; Humans; Male; Middle Aged; Neoplasms, Unknown Primary; Radiography; Radiotherapy Dosage

2009
Primary meningeal CNS lymphoma treated with intra-arterial chemotherapy and blood-brain barrier disruption.
    Journal of neuro-oncology, 2008, Volume: 90, Issue:3

    Topics: Antineoplastic Agents; Blood-Brain Barrier; Central Nervous System Neoplasms; Enzyme Inhibitors; Etoposide; Female; Humans; Injections, Intra-Arterial; Injections, Intravenous; Lymphoma, Large-Cell, Immunoblastic; Magnetic Resonance Imaging; Methotrexate; Middle Aged; Organophosphorus Compounds

2008
Outcome of patients with recurrent medulloblastoma or central nervous system germinoma treated with low dose continuous intravenous etoposide along with dose-intensive chemotherapy followed by autologous hematopoietic stem cell rescue.
    Pediatric blood & cancer, 2009, Volume: 53, Issue:1

    Topics: Adolescent; Adult; Anemia; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Central Nervous System Neoplasms; Child; Child, Preschool; Etoposide; Female; Germinoma; Hematologic Diseases; Hematopoietic Stem Cell Transplantation; Humans; Infusions, Intravenous; Male; Neoplasm Recurrence, Local; Survival Rate; Thiotepa; Treatment Outcome

2009
A successful treatment of relapsed primary CNS lymphoma patient with intraventricular rituximab followed by high-dose chemotherapy with autologous stem cell rescue.
    Yonsei medical journal, 2009, Apr-30, Volume: 50, Issue:2

    Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Central Nervous System Neoplasms; Cytarabine; Etoposide; Female; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Middle Aged; Rituximab; Stem Cell Transplantation

2009
Retinoblastoma CSF metastasis cured by multimodality chemotherapy without radiation.
    Ophthalmic genetics, 2009, Volume: 30, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Central Nervous System Neoplasms; Cerebrospinal Fluid; Combined Modality Therapy; Cord Blood Stem Cell Transplantation; Cyclophosphamide; Cytarabine; Etoposide; Eye Enucleation; Humans; Infant; Male; Prognosis; Retinal Neoplasms; Retinoblastoma; Transplantation, Autologous; Treatment Outcome; Vincristine

2009
Treatment of primary CNS germinomatous germ cell tumors with chemotherapy prior to reduced dose whole ventricular and local boost irradiation.
    Pediatric blood & cancer, 2010, Jul-15, Volume: 55, Issue:1

    Topics: Adolescent; Adult; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Central Nervous System Neoplasms; Child; Child, Preschool; Chorionic Gonadotropin, beta Subunit, Human; Combined Modality Therapy; Dose-Response Relationship, Radiation; Etoposide; Female; Germinoma; Humans; Infant; Magnetic Resonance Imaging; Male; Neoplasms, Germ Cell and Embryonal; Retrospective Studies; Young Adult

2010
Diffuse infiltrating retinoblastoma with central nervous system metastasis.
    Archives of ophthalmology (Chicago, Ill. : 1960), 2011, Volume: 129, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Central Nervous System Neoplasms; Child; Combined Modality Therapy; Cranial Irradiation; Cytarabine; Etoposide; Humans; Hydrocortisone; Infusions, Intravenous; Injections, Spinal; Magnetic Resonance Imaging; Male; Methotrexate; Retinal Neoplasms; Retinoblastoma; Vincristine

2011
Chemosensitization of glioblastoma cells by the histone deacetylase inhibitor MS275.
    Anti-cancer drugs, 2011, Volume: 22, Issue:6

    Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Apoptosis; Benzamides; Blotting, Western; Cell Line, Tumor; Central Nervous System Neoplasms; Cisplatin; Dacarbazine; Doxorubicin; Drug Synergism; Etoposide; Glioblastoma; Histone Deacetylase Inhibitors; Histones; Humans; Microtubules; Pyridines; Temozolomide

2011
Platine and cytarabine-based salvage treatment for primary central nervous system lymphoma.
    Journal of neuro-oncology, 2011, Volume: 105, Issue:2

    Topics: Adult; Aged; Anti-Inflammatory Agents; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Central Nervous System Neoplasms; Cisplatin; Cytarabine; Dexamethasone; Etoposide; Female; Follow-Up Studies; Humans; Lymphoma; Male; Methylprednisolone; Middle Aged; Neoplasm Recurrence, Local; Prognosis; Retrospective Studies; Rituximab; Salvage Therapy; Thiotepa; Young Adult

2011
Long-term survival in patients with newly diagnosed primary central nervous system lymphoma treated with dexamethasone, etoposide, ifosfamide and carboplatin chemotherapy and whole-brain radiation therapy.
    Leukemia & lymphoma, 2011, Volume: 52, Issue:11

    Topics: Adult; Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Central Nervous System Neoplasms; Chemoradiotherapy; Cognition Disorders; Dexamethasone; Etoposide; Female; Humans; Ifosfamide; Kaplan-Meier Estimate; Leukopenia; Lymphoma; Male; Middle Aged; Outcome Assessment, Health Care; Radiotherapy; Retrospective Studies; Survivors; Young Adult

2011
CNS disease in younger patients with aggressive B-cell lymphoma: an analysis of patients treated on the Mabthera International Trial and trials of the German High-Grade Non-Hodgkin Lymphoma Study Group.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2012, Volume: 23, Issue:5

    Topics: Adolescent; Adult; Age of Onset; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Cyclophosphamide; Doxorubicin; Etoposide; Female; Germany; Humans; International Cooperation; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Male; Medical Oncology; Methotrexate; Middle Aged; Multicenter Studies as Topic; Neoplasm Grading; Neoplasm Invasiveness; Prednisolone; Prednisone; Rituximab; Societies, Medical; Vincristine; Young Adult

2012
Sensitization of glioma cells by X-linked inhibitor of apoptosis protein knockdown.
    Oncology, 2012, Volume: 83, Issue:2

    Topics: Antineoplastic Agents; Apoptosis; Caspases; Cellular Senescence; Central Nervous System Neoplasms; DNA Damage; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Gene Knockdown Techniques; Glioma; Humans; RNA, Small Interfering; Tumor Suppressor Protein p53; Vincristine; X-Linked Inhibitor of Apoptosis Protein

2012
Salvage chemoimmunotherapy with rituximab, ifosfamide and etoposide (R-IE regimen) in patients with primary CNS lymphoma relapsed or refractory to high-dose methotrexate-based chemotherapy.
    Hematological oncology, 2013, Volume: 31, Issue:3

    Topics: Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Combined Modality Therapy; Cranial Irradiation; Cranial Nerve Neoplasms; Drug Administration Schedule; Drug Evaluation; Drug Resistance, Neoplasm; Etoposide; Eye Neoplasms; Female; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Kaplan-Meier Estimate; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Middle Aged; Peripheral Blood Stem Cell Transplantation; Recurrence; Remission Induction; Retrospective Studies; Rituximab; Salvage Therapy; Survival Analysis; Transplantation, Autologous; Treatment Outcome

2013
Successful treatment of primary central nervous system lymphoma without irradiation in children: single center experience.
    Journal of Korean medical science, 2012, Volume: 27, Issue:11

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Hydrocortisone; Infant; Leucovorin; Lymphoma, Non-Hodgkin; Male; Methotrexate; Prednisone; Recurrence; Retrospective Studies; Tomography, X-Ray Computed; Treatment Outcome; Vincristine

2012
Current status and future of relapsed primary central nervous system lymphoma (PCNSL).
    Leukemia & lymphoma, 2003, Volume: 44, Issue:4

    Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Central Nervous System Neoplasms; Cyclophosphamide; Disease-Free Survival; Etoposide; Female; Humans; Lymphoma; Male; Methotrexate; Middle Aged; Organophosphorus Compounds; Radioimmunotherapy; Recurrence; Rituximab; Time Factors

2003
Intensive methotrexate and cytarabine followed by high-dose chemotherapy with autologous stem-cell rescue in patients with newly diagnosed primary CNS lymphoma: an intent-to-treat analysis.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2003, Nov-15, Volume: 21, Issue:22

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Central Nervous System Neoplasms; Combined Modality Therapy; Cytarabine; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, Non-Hodgkin; Male; Melphalan; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Prospective Studies; Remission Induction; Safety; Salvage Therapy; Survival Rate; Transplantation, Autologous; Treatment Outcome

2003
Primary chemotherapy for intracranial nongerminomatous germ cell tumors: results of the second international CNS germ cell study group protocol.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2004, Mar-01, Volume: 22, Issue:5

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Central Nervous System Neoplasms; Child; Child, Preschool; Cisplatin; Cohort Studies; Confidence Intervals; Cyclophosphamide; Disease-Free Survival; Dose-Response Relationship, Drug; Drug Administration Schedule; Etoposide; Female; Germinoma; Humans; Infusions, Intravenous; International Cooperation; Male; Middle Aged; Probability; Prognosis; Prospective Studies; Risk Assessment; Salvage Therapy; Statistics, Nonparametric; Survival Analysis; Treatment Outcome

2004
Metastatic lung disease to the central nervous system: in vitro response to chemotherapeutic agents.
    Journal of neuro-oncology, 2004, Volume: 66, Issue:1-2

    Topics: Adenocarcinoma; Adenocarcinoma, Papillary; Aged; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Carboplatin; Carcinoma, Squamous Cell; Central Nervous System Neoplasms; Cisplatin; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Etoposide; Female; Humans; Lomustine; Lung Neoplasms; Male; Middle Aged; Tumor Cells, Cultured

2004
[Results of intensive chemotherapy followed by hematopoietic stem-cell rescue in 22 patients with refractory or recurrent primary CNS lymphoma or intraocular lymphoma].
    Bulletin du cancer, 2004, Volume: 91, Issue:2

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Central Nervous System Neoplasms; Combined Modality Therapy; Cytarabine; Etoposide; Eye Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Large-Cell, Immunoblastic; Lymphoma, T-Cell; Middle Aged; Prognosis; Recurrence; Thiotepa

2004
Modified ProMACE-MOPP hybrid regimen with moderate-dose methotrexate for patients with primary CNS lymphoma.
    Annals of hematology, 2005, Volume: 84, Issue:7

    Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Cranial Irradiation; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Leukopenia; Lymphoma; Male; Mechlorethamine; Methotrexate; Middle Aged; Pneumonia; Prednisone; Procarbazine; Retrospective Studies; Sepsis; Vincristine

2005
[Medulloblastoma with mandibular metastasis after complete remission of the central nervous system lesions].
    No to shinkei = Brain and nerve, 2005, Volume: 57, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Cerebellar Neoplasms; Cerebral Ventricle Neoplasms; Child; Combined Modality Therapy; Cranial Irradiation; Craniotomy; Etoposide; Humans; Magnetic Resonance Imaging; Male; Mandibular Neoplasms; Medulloblastoma; Nimustine; Remission Induction

2005
Combining etoposide and dexrazoxane synergizes with radiotherapy and improves survival in mice with central nervous system tumors.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2005, Sep-15, Volume: 11, Issue:18

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Blood-Brain Barrier; Central Nervous System Neoplasms; Combined Modality Therapy; DNA Damage; DNA, Neoplasm; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Etoposide; Female; Mice; Mice, Inbred Strains; Neoplasms, Experimental; Razoxane; Survival Analysis; Time Factors; Treatment Outcome; Tumor Cells, Cultured

2005
Outcome for young high-risk aggressive B-cell lymphoma patients treated with CHOEP-14 and rituximab (R-CHOEP-14).
    Medical oncology (Northwood, London, England), 2006, Volume: 23, Issue:2

    Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Cyclophosphamide; Cytarabine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Follow-Up Studies; Granulocyte Colony-Stimulating Factor; Humans; Lymphoma, B-Cell; Male; Middle Aged; Prednisolone; Recombinant Proteins; Recurrence; Retrospective Studies; Rituximab; Vincristine

2006
Management of gestational trophoblastic neoplasia with metastasis to the central nervous system: A 12-year review at the Philippine General Hospital.
    The Journal of reproductive medicine, 2006, Volume: 51, Issue:10

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Injections, Spinal; Medical Records; Methotrexate; Middle Aged; Neoplasm Metastasis; Philippines; Pregnancy; Retrospective Studies; Survival Analysis; Uterine Neoplasms; Vincristine

2006
Collagen gel matrix assay as an in vitro chemosensitivity test for malignant astrocytic tumors.
    International journal of clinical oncology, 2007, Volume: 12, Issue:2

    Topics: Adult; Aged; Antineoplastic Agents; Astrocytoma; Carboplatin; Central Nervous System Neoplasms; Cisplatin; Collagen; Disease Progression; Disease-Free Survival; Drug Screening Assays, Antitumor; Etoposide; Female; Fibrin Foam; Follow-Up Studies; Glioblastoma; Humans; Japan; Karnofsky Performance Status; Male; Middle Aged; Nimustine; Sensitivity and Specificity; Survival Analysis; Tissue Adhesives; Treatment Outcome; Tumor Burden; Tumor Cells, Cultured

2007
Unexpected dementia following prophylactic cranial irradiation for small cell lung cancer: case report.
    Journal of neuro-oncology, 2007, Volume: 85, Issue:1

    Topics: Aged; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Carboplatin; Carcinoma, Small Cell; Central Nervous System Neoplasms; Combined Modality Therapy; Dementia; Etoposide; Female; Humans; Lung Neoplasms; Memory Disorders; Radiotherapy

2007
High-dose chemotherapy with autologous stem cell transplantation in adults with recurrent embryonal tumors of the central nervous system.
    Cancer, 2008, Apr-15, Volume: 112, Issue:8

    Topics: Adult; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Central Nervous System Neoplasms; Cisplatin; Cohort Studies; Disease Progression; Etoposide; Female; Follow-Up Studies; Humans; Lomustine; Male; Medulloblastoma; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Procarbazine; Retrospective Studies; Stem Cell Transplantation; Survival Rate; Thiotepa; Transplantation, Autologous

2008
Results of treatment of 112 cases of primary CNS lymphoma.
    Japanese journal of clinical oncology, 2008, Volume: 38, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Chemotherapy, Adjuvant; Cognition; Cranial Irradiation; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Kaplan-Meier Estimate; Karnofsky Performance Status; Leucovorin; Lymphoma; Male; Mechlorethamine; Methotrexate; Middle Aged; Neoplasm Staging; Prednisone; Procarbazine; Radiotherapy, Adjuvant; Retrospective Studies; Salvage Therapy; Treatment Outcome; Vincristine

2008
[Treatment outcome of primary central nervous system germ cell tumors after combined therapy: a report of 23 cases].
    Ai zheng = Aizheng = Chinese journal of cancer, 2008, Volume: 27, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Central Nervous System Neoplasms; Cisplatin; Combined Modality Therapy; Etoposide; Female; Humans; Male; Neoplasms, Germ Cell and Embryonal; Survival Rate

2008
[Two cases of adult T-cell leukemia . lymphoma (ATL) with long-term remission by chronic daily administration of low-dose etoposide].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1995, Volume: 22, Issue:4

    Topics: Administration, Oral; Adult; Central Nervous System Neoplasms; Drug Administration Schedule; Etoposide; Female; Humans; Leukemia-Lymphoma, Adult T-Cell; Male; Middle Aged; Prognosis; Skin Neoplasms

1995
ICRF-187 rescue in etoposide treatment in vivo. A model targeting high-dose topoisomerase II poisons to CNS tumors.
    Cancer chemotherapy and pharmacology, 1996, Volume: 38, Issue:3

    Topics: Amsacrine; Animals; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Blood-Brain Barrier; Brain Neoplasms; Carcinoma, Ehrlich Tumor; Central Nervous System Neoplasms; DNA Topoisomerases, Type II; Etoposide; Female; Injections, Intraperitoneal; Lethal Dose 50; Leukemia L1210; Male; Mice; Mice, Inbred DBA; Paclitaxel; Razoxane; Structure-Activity Relationship

1996
[Paraplegia following intrathecal chemotherapy].
    Schweizerische medizinische Wochenschrift, 1996, Jun-22, Volume: 126, Issue:25

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Cisplatin; Cytarabine; Etoposide; Humans; Injections, Spinal; Male; Paraplegia; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone

1996
What is the best method of prevention of therapeutic failures in CNS in high risk retinoblastoma?
    Medical and pediatric oncology, 1997, Volume: 28, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Child, Preschool; Chlorambucil; Etoposide; Humans; Male; Orbital Neoplasms; Prednisolone; Retinoblastoma; Risk Factors; Vincristine

1997
Clinical efficacy of perceived 'CNS friendly' chemoradiotherapy for primary intracranial germ cell tumours.
    Clinical oncology (Royal College of Radiologists (Great Britain)), 1997, Volume: 9, Issue:1

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Central Nervous System Neoplasms; Child; Combined Modality Therapy; Etoposide; Female; Humans; Magnetic Resonance Imaging; Male; Neoplasms, Germ Cell and Embryonal; Radiotherapy Dosage; Radiotherapy, High-Energy; Remission Induction; Vincristine

1997
Systemic chemotherapy alone for patients with non-acquired immunodeficiency syndrome-related central nervous system lymphoma: a pilot study of the BOMES protocol.
    Cancer, 1998, May-15, Volume: 82, Issue:10

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Central Nervous System Neoplasms; Disease Progression; Etoposide; Female; Humans; Lymphoma, AIDS-Related; Male; Methotrexate; Methylprednisolone Hemisuccinate; Middle Aged; Pilot Projects; Prospective Studies; Survival Rate; Treatment Outcome; Vincristine

1998
High-dose chemotherapy with carboplatin, etoposide and cyclophosphamide followed by a haematopoietic stem cell rescue in patients with high-risk retinoblastoma: a SFOP and SFGM study.
    European journal of cancer (Oxford, England : 1990), 1997, Volume: 33, Issue:14

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Central Nervous System Neoplasms; Child; Child, Preschool; Cyclophosphamide; Disease-Free Survival; Etoposide; Female; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Humans; Infant; Kidney Diseases; Male; Neutropenia; Retinal Neoplasms; Retinoblastoma

1997
[Successful treatment with high dose chemotherapy following peripheral blood stem cell transplantation for relapsed Burkitt's lymphoma with central nervous system involvement].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 1998, Volume: 39, Issue:11

    Topics: Adult; Anti-Inflammatory Agents; Antimetabolites, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Carboplatin; Central Nervous System Neoplasms; Cyclophosphamide; Cytarabine; Dexamethasone; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Male; Transplantation, Autologous

1998
Patterns of central nervous system recurrence in patients with systemic human immunodeficiency virus-associated non-hodgkin lymphoma.
    Cancer, 1999, Nov-01, Volume: 86, Issue:9

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Lymphoma, AIDS-Related; Male; Meningitis; Middle Aged; Prospective Studies; Secondary Prevention

1999
High-dose therapy with hematopoietic cell transplantation for patients with central nervous system involvement by non-Hodgkin's lymphoma.
    Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2000, Volume: 6, Issue:3A

    Topics: Actuarial Analysis; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Purging; Carmustine; Central Nervous System; Central Nervous System Neoplasms; Cognition Disorders; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Disease Progression; Disease-Free Survival; Etoposide; Female; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Myelitis, Transverse; Neoplasm Invasiveness; Quality of Life; Radiation Injuries; Survival Analysis; Survival Rate; Transplantation Conditioning; Treatment Outcome; Whole-Body Irradiation

2000
High-dose carmustine, thiotepa and etoposide followed by autologous bone marrow rescue for the treatment of high risk central nervous system tumors.
    Bone marrow transplantation, 2000, Volume: 26, Issue:2

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carmustine; Central Nervous System Neoplasms; Chemical and Drug Induced Liver Injury; Child; Child, Preschool; Combined Modality Therapy; Disease-Free Survival; Etoposide; Female; Graft Survival; Hematologic Diseases; Humans; Infant; Kidney Diseases; Lung Diseases; Male; Middle Aged; Multiple Organ Failure; Nervous System Diseases; Survival Rate; Thiotepa; Transplantation, Autologous; Treatment Outcome

2000
Epstein-Barr virus-associated lymphoma in a child undergoing an autologous stem cell rescue.
    Journal of pediatric hematology/oncology, 2002, Volume: 24, Issue:2

    Topics: Acyclovir; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Carboplatin; Central Nervous System Neoplasms; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Disease Progression; Epstein-Barr Virus Infections; Etoposide; Eye Enucleation; Eye Neoplasms; Fatal Outcome; Hematopoietic Stem Cell Transplantation; Herpesvirus 4, Human; Humans; Immunocompromised Host; Immunoglobulins, Intravenous; Immunosuppressive Agents; Immunotherapy; Lymphoma, Large B-Cell, Diffuse; Male; Meningeal Neoplasms; Methylprednisolone; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Optic Nerve Neoplasms; Radiotherapy, Adjuvant; Retinoblastoma; Rituximab; Thiotepa; Vincristine

2002
Combination chemotherapy with ifosfamide and etoposide is effective in the treatment of central nervous system metastasis of childhood neuroblastoma.
    Cancer, 1992, Jun-15, Volume: 69, Issue:12

    Topics: Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Etoposide; Female; Humans; Ifosfamide; Infant; Neuroblastoma

1992
Intensive weekly combination chemotherapy for patients with intermediate-grade and high-grade non-Hodgkin's lymphoma.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1991, Volume: 9, Issue:12

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Central Nervous System Neoplasms; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm Staging; Prednisone; Survival Analysis; Vincristine

1991